LogMeIn and Bioverativ Set to Join the S&P MidCap 400; Others to Join S&P SmallCap 600

Go back to LogMeIn and Bioverativ Set to Join the S&P MidCap 400; Others to Join S&P SmallCap 600

Mizuho Securities Reiterates Buy on Citrix Systems (CTXS) Following 4Q Beat

January 26, 2017 9:17 AM EST

Mizuho Securities reiterated a Buy rating and $100.00 price target on Citrix Systems (NASDAQ: CTXS) following the company's 4Q earnings report. Citrix reported revenues and EPS of $908mm and $1.61, which compared with guidance of $890-900mm and $1.48-1.50 and consensus of $901mm and $1.49,... More